+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Montelukast Sodium Granules Market - Global Forecast 2026-2032- Product Image
Montelukast Sodium Granules Market - Global Forecast 2026-2032- Product Image
Sale

Montelukast Sodium Granules Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6146835
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Montelukast Sodium Granules Market is projected to reach USD 682.47 Million in 2026. It is expected to continue growing at a CAGR of 11.26%, reaching USD 1.31 Billion by 2032.

Montelukast Sodium Granules: Executive Overview

Montelukast sodium granules are an oral dosage form used in pediatric respiratory care, particularly where swallowing tablets is difficult. Their clinical relevance is linked to montelukast’s established role as a leukotriene receptor antagonist for asthma and allergic rhinitis. Demand conditions are shaped by pediatric prescribing practices, regulatory requirements, caregiver preferences, and the availability of age-appropriate formulations. Clinical use should follow approved indications and current safety guidance, including attention to the product’s boxed warning regarding serious neuropsychiatric events in the United States.

Pediatric Formulation Needs Are Reshaping Respiratory Treatment

The landscape is shifting toward formulations that support accurate administration, easier swallowing, and adherence among children. Granules can be administered directly or mixed with approved soft foods, subject to product instructions, which may help address pediatric usability challenges. At the same time, regulators and clinicians are placing greater emphasis on benefit-risk assessment, responsible use in allergic rhinitis, pharmacovigilance, supply continuity, and clear caregiver counseling. These changes favor manufacturers and healthcare systems that combine formulation reliability with strong patient-information practices.

Artificial Intelligence Strengthens Safety, Quality, and Supply Decisions

Artificial intelligence can support this market by identifying potential safety signals from large-scale pharmacovigilance data, improving review of adverse-event narratives, and helping prioritize cases for clinical assessment. In manufacturing, machine-learning tools may assist process monitoring, deviation detection, visual inspection, and predictive maintenance, provided that validated controls and human oversight remain in place. AI can also improve demand planning and inventory monitoring, but its outputs should be governed through documented validation, data-quality controls, cybersecurity safeguards, and compliance with applicable pharmaceutical regulations.

Regional Differences Reflect Regulation, Access, and Pediatric Care Practices

North America is characterized by formal regulatory scrutiny, strong pharmacovigilance expectations, and heightened awareness of montelukast’s neuropsychiatric safety communication. Latin America presents varied regulatory pathways and differences in public and private access, making local registration, distribution resilience, and caregiver education important. Europe emphasizes harmonized scientific standards alongside national reimbursement and prescribing practices. The Middle East combines advanced healthcare infrastructure in some markets with import dependence and access variation across countries. Africa faces uneven availability, health-system capacity constraints, and the need for practical pediatric dosing education. Asia-Pacific includes diverse regulatory environments, substantial pediatric populations, and growing attention to locally appropriate, quality-assured oral formulations.

Economic and Security Groupings Create Distinct Operating Contexts

ASEAN markets require attention to differing national registrations, procurement systems, and language needs despite regional cooperation. BRICS members span varied regulatory maturity, manufacturing capabilities, and public-health priorities, making country-specific compliance and supply planning essential. The European Union benefits from coordinated regulatory structures while retaining national differences in reimbursement and clinical practice. G7 markets generally maintain demanding quality, safety, and evidence requirements, with strong expectations for transparent risk communication. GCC countries often depend on coordinated procurement and imported medicines, while local regulatory alignment remains important. NATO members do not constitute a unified pharmaceutical market, but their overlapping emphasis on health security and supply resilience can influence continuity planning and critical-medicine preparedness.

Country-Level Priorities Range from Safety Communication to Local Access

Australia emphasizes a regulated medicines framework and pediatric safety communication. Brazil combines a large public health system with country-specific registration and procurement considerations. Canada requires attention to federal regulatory expectations and bilingual communication. China’s market is shaped by evolving regulatory standards, domestic manufacturing capacity, and regional access differences. France, Germany, Italy, and Spain operate within the European framework but retain distinct prescribing, reimbursement, and procurement dynamics. India combines broad pharmaceutical manufacturing capabilities with varied healthcare access and regulatory implementation. Japan places strong emphasis on quality, labeling, and pediatric clinical appropriateness. Mexico requires navigation of national registration and mixed public-private distribution. Russia presents a distinct regulatory and supply environment requiring localized compliance assessment. South Korea emphasizes rigorous quality standards and advanced healthcare delivery. The United Kingdom maintains a separate post-EU regulatory and reimbursement context. The United States places particular importance on boxed-warning communication, indication-specific use, and ongoing adverse-event monitoring.

Prioritize Formulation Quality, Responsible Use, and Supply Resilience

Industry leaders should maintain validated granule uniformity, dose accuracy, stability, packaging performance, and contamination controls across the product lifecycle. They should align labeling and educational materials with current regulatory safety communications, especially for neuropsychiatric risks, and provide clear instructions for administration and storage. Regional strategies should be adapted to registration, reimbursement, procurement, and language requirements rather than treated as interchangeable. Supply-chain programs should qualify multiple sources where feasible, monitor critical materials, and use data-driven early-warning systems for disruption. Finally, organizations should apply AI only within validated, auditable workflows and measure outcomes through quality, adherence, safety-reporting, and service-continuity indicators.

Methodology: Triangulating Regulatory, Clinical, and Supply-Side Evidence

This executive summary uses a structured qualitative review of the product category, its pediatric formulation characteristics, established therapeutic context, and documented regulatory safety considerations. Analysis is organized across six required regions, six economic or security groupings, and fifteen countries to identify differences in access, oversight, healthcare delivery, and operational requirements. The approach prioritizes authoritative regulatory communications, approved product information, clinical guidance, peer-reviewed evidence, and publicly documented pharmaceutical-quality principles. No market estimates, market shares, forecasts, or company-specific claims are used. Findings should be validated against current national labeling, regulatory decisions, and local clinical guidance before operational or medical decisions are made.

Responsible Execution Will Define the Category’s Next Stage

Montelukast sodium granules occupy an important niche in pediatric respiratory treatment because they address administration challenges that conventional solid oral forms may not. However, sustainable adoption depends on disciplined patient selection, transparent safety communication, consistent product quality, and dependable access. Regional and country differences require localized regulatory and healthcare strategies, while AI can add value only when supported by validated data and accountable human review. Leaders that integrate these priorities can strengthen patient-centered use without overstating the medicine’s role or overlooking its established safety considerations.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Montelukast Sodium Granules Market, by Patient Age Group
7.1. Introduction
7.2. Adult
7.3. Pediatric
7.3.1. 2 To 5 Years
7.3.2. 6 To 14 Years
8. Montelukast Sodium Granules Market, by Dosage Strength
8.1. Introduction
8.2. 4 Milligram
8.3. 5 Milligram
9. Montelukast Sodium Granules Market, by Application
9.1. Introduction
9.2. Asthma
9.3. Exercise Induced Bronchoconstriction
9.4. Perennial Allergic Rhinitis
9.5. Seasonal Allergic Rhinitis
10. Montelukast Sodium Granules Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Montelukast Sodium Granules Market, by End User
11.1. Introduction
11.2. Clinic
11.3. Home Care
11.4. Hospital
12. Montelukast Sodium Granules Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Montelukast Sodium Granules Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Montelukast Sodium Granules Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Amneal Pharmaceuticals, Inc..
16.2. Apotex Inc
16.3. Aurobindo Pharma Ltd.
16.4. Cipla Limited
16.5. Dr. Reddy’s Laboratories Ltd.
16.6. Glenmark Pharmaceuticals Ltd.
16.7. Intas Pharmaceuticals Ltd..
16.8. Lupin Limited
16.9. Macleods Pharmaceuticals Ltd..
16.10. Merck & Co., Inc.
16.11. Sandoz Inc.
16.12. Sanofi S.A..
16.13. Sun Pharmaceutical Industries Ltd.
16.14. Teva Pharmaceuticals USA, Inc.
16.15. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Montelukast Sodium Granules Market, Years Considered for the Study
FIGURE 2. Global Montelukast Sodium Granules Market, Research Design
FIGURE 3. Global Montelukast Sodium Granules Market, Research Framework
FIGURE 4. Global Montelukast Sodium Granules Market, Data Triangulation
FIGURE 5. Global Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Montelukast Sodium Granules Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 7. Global Montelukast Sodium Granules Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Montelukast Sodium Granules Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 9. Global Montelukast Sodium Granules Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Montelukast Sodium Granules Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Montelukast Sodium Granules Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Montelukast Sodium Granules Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Montelukast Sodium Granules Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Montelukast Sodium Granules Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Montelukast Sodium Granules Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Montelukast Sodium Granules Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Montelukast Sodium Granules Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Montelukast Sodium Granules Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Montelukast Sodium Granules Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Montelukast Sodium Granules Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Montelukast Sodium Granules Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Montelukast Sodium Granules Market Segmentation & Coverage
TABLE 2. Global Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 3. Global Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 4. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 2 To 5 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 2 To 5 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 2 To 5 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 6 To 14 Years Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 6 To 14 Years Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 6 To 14 Years Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 17. Global 4 Milligram Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global 4 Milligram Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global 4 Milligram Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global 5 Milligram Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global 5 Milligram Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global 5 Milligram Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Asthma Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Asthma Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Asthma Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Exercise Induced Bronchoconstriction Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Exercise Induced Bronchoconstriction Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Exercise Induced Bronchoconstriction Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Perennial Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Perennial Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Perennial Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Seasonal Allergic Rhinitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Seasonal Allergic Rhinitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Seasonal Allergic Rhinitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 37. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. North America Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 66. North America Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 67. North America Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 68. North America Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. North America Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 70. North America Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 71. Latin America Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Latin America Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 73. Latin America Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 74. Latin America Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 75. Latin America Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Latin America Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Latin America Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Europe Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Europe Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 80. Europe Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 81. Europe Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 82. Europe Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. Europe Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 84. Europe Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Middle East Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Middle East Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 87. Middle East Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 88. Middle East Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 89. Middle East Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Middle East Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Middle East Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Africa Montelukast Sodium Granules Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Africa Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 94. Africa Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 95. Africa Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 96. Africa Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Africa Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 98. Africa Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Global Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 102. ASEAN Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 103. ASEAN Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 104. ASEAN Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. ASEAN Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. ASEAN Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. GCC Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. GCC Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 109. GCC Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 110. GCC Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 111. GCC Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. GCC Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 113. GCC Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. European Union Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. European Union Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 116. European Union Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 117. European Union Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 118. European Union Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. European Union Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. European Union Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. BRICS Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. BRICS Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 123. BRICS Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 124. BRICS Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 125. BRICS Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. BRICS Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. BRICS Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. G7 Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. G7 Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 130. G7 Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 131. G7 Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 132. G7 Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. G7 Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. G7 Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. NATO Montelukast Sodium Granules Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. NATO Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 137. NATO Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 138. NATO Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 139. NATO Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. NATO Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 141. NATO Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Global Montelukast Sodium Granules Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. United States Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 144. United States Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 145. United States Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 146. United States Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 147. United States Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. United States Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 149. United States Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. Canada Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 151. Canada Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 152. Canada Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 153. Canada Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 154. Canada Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Canada Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. Canada Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Mexico Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 158. Mexico Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 159. Mexico Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 160. Mexico Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 161. Mexico Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Mexico Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Mexico Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Brazil Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 165. Brazil Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 166. Brazil Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 167. Brazil Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 168. Brazil Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Brazil Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. Brazil Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. United Kingdom Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 172. United Kingdom Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 173. United Kingdom Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 174. United Kingdom Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 175. United Kingdom Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. United Kingdom Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. United Kingdom Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Germany Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 179. Germany Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 180. Germany Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 181. Germany Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 182. Germany Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Germany Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 184. Germany Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. France Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 186. France Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 187. France Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 188. France Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 189. France Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. France Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. France Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. Russia Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 193. Russia Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 194. Russia Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 195. Russia Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 196. Russia Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Russia Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Russia Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Italy Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 200. Italy Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 201. Italy Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 202. Italy Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 203. Italy Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Italy Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Italy Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Spain Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 207. Spain Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 208. Spain Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 209. Spain Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 210. Spain Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Spain Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 212. Spain Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. China Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 214. China Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 215. China Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 216. China Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 217. China Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. China Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 219. China Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. India Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 221. India Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 222. India Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 223. India Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 224. India Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. India Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. India Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Japan Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 228. Japan Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 229. Japan Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 230. Japan Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 231. Japan Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Japan Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Japan Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. Australia Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 235. Australia Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 236. Australia Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 237. Australia Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 238. Australia Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Australia Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 240. Australia Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. South Korea Montelukast Sodium Granules Market Size, 2017-2032 (USD Million)
TABLE 242. South Korea Montelukast Sodium Granules Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 243. South Korea Montelukast Sodium Granules Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 244. South Korea Montelukast Sodium Granules Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 245. South Korea Montelukast Sodium Granules Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. South Korea Montelukast Sodium Granules Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. South Korea Montelukast Sodium Granules Market Size, by End User, 2017-2032 (USD Million)
TABLE 248. Global Montelukast Sodium Granules Market Share, by Key Player, 2025
TABLE 249. Global Montelukast Sodium Granules Market, Key Experts

Companies Mentioned

  • Amneal Pharmaceuticals, Inc..
  • Apotex Inc
  • Aurobindo Pharma Ltd.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd..
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd..
  • Merck & Co., Inc.
  • Sandoz Inc.
  • Sanofi S.A..
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals USA, Inc.
  • Viatris Inc.

Related Topics

Related Reports

Montelukast Sodium Market - Global Forecast 2026-2032 - Product Image

Montelukast Sodium Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Montelukast Sodium - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Montelukast Sodium - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Montelukast Sodium Market Report 2026 - Product Image

Montelukast Sodium Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Montelukast Sodium Market Outlook 2026-2034: Market Share and Growth Analysis by Dosage Form (Tablets, Film-coated Tablets, Chewable Tablets, Dispersible / Fast-dissolving Tablets, Oral Solutions/Syrups, Oral Granules, Other Forms), Application - Product Image

Montelukast Sodium Market Outlook 2026-2034: Market Share and Growth Analysis by Dosage Form (Tablets, Film-coated Tablets, Chewable Tablets, Dispersible / Fast-dissolving Tablets, Oral Solutions/Syrups, Oral Granules, Other Forms), Application

  • Report
  • 160 Pages
  • Global
From
Montelukast Sodium - Global Strategic Business Report - Product Image

Montelukast Sodium - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.